Bosh sahifaNBY โข NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
0,63ย $
Seans yopilganidan keyin:(3,26%)+0,021
0,65ย $
Yopilgan:3-iyl, 14:06:54 (GMT-4) · USD · NYSEAMERICAN · Ogohlantirish
Yopilish kursi
0,63ย $
Kunlik diapazon
0,60ย $ - 0,64ย $
Yillik diapazon
0,36ย $ - 2,45ย $
Bozor kapitalizatsiyasi
3,63ย mln USD
Oสปrtacha hajm
27,34ย ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Daromad | โ | โ |
Joriy xarajat | 2,70ย mln | 17,90% |
Sof foyda | 7,67ย mln | 338,64% |
Sof foyda marjasi | โ | โ |
Har bir ulushga tushum | โ | โ |
EBITDA | -2,70ย mln | -18,43% |
Amaldagi soliq stavkasi | โ | โ |
Balans
Jami aktivlari
Jami passivlari
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 8,47ย mln | 364,45% |
Jami aktivlari | 9,87ย mln | 84,28% |
Jami passivlari | 3,70ย mln | -28,71% |
Umumiy kapital | 6,17ย mln | โ |
Tarqatilgan aksiyalar | 5,82ย mln | โ |
Narxi/balansdagi bahosi | 0,59 | โ |
Aktivlardan daromad | -101,58% | โ |
Kapitaldan daromad | -152,86% | โ |
Pul aylanmasi
Naqd pulning sof oสปzgarishi
(USD) | mar, 2025info | Y/Y qiyosi |
---|---|---|
Sof foyda | 7,67ย mln | 338,64% |
Operatsiyalardan naqd pul | 9,74ย mln | 1ย 476,41% |
Sarmoyadan naqd pul | โ | โ |
Moliyadan naqd pul | -1,71ย mln | -186,10% |
Naqd pulning sof oสปzgarishi | 8,04ย mln | 714,92% |
Boสปsh pul | 28,88ย ming | -97,37% |
Haqida
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.
and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Tashkil etilgan
2000
Sayt
Xodimlar soni
14